Other Liabilities, Noncurrent of ACCENDRA HEALTH INC/VA/ from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Other Liabilities, Noncurrent in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • ACCENDRA HEALTH INC/VA/ Other Liabilities, Noncurrent for the quarter ending 30 Sep 2025 was $83,153,000, a 29% decline year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $83,153,000 -$33,330,000 -29% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $84,960,000 -$28,729,000 -25% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $87,376,000 -$35,889,000 -29% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $72,551,000 -$50,041,000 -41% 31 Dec 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $116,483,000 -$4,113,000 -3.4% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $113,689,000 -$6,329,000 -5.3% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $123,265,000 -$80,000 -0.06% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $122,592,000 +$7,649,000 +6.7% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $120,596,000 -$3,221,000 -2.6% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $120,018,000 -$13,939,000 -10% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $123,345,000 -$15,462,000 -11% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $114,943,000 +$6,005,000 +5.5% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $123,817,000 +$2,308,000 +1.9% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $133,957,000 +$26,635,000 +25% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $138,807,000 +$34,927,000 +34% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $108,938,000 -$12,329,000 -10% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $121,509,000 +$413,000 +0.34% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $107,322,000 -$9,984,000 -8.5% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $103,880,000 -$8,295,000 -7.4% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $121,267,000 +$22,541,000 +23% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $121,096,000 +$23,146,000 +24% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $117,306,000 +$24,518,000 +26% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $112,175,000 +$24,308,000 +28% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $98,726,000 +$21,036,000 +27% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $97,950,000 +$21,727,000 +29% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $92,788,000 +$8,570,000 +10% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $87,867,000 +$11,462,000 +15% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $77,690,000 +$1,600,000 +2.1% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $76,223,000 +$4,937,000 +6.9% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $84,218,000 +$14,945,000 +22% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $76,405,000 +$7,768,000 +11% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $76,090,000 +$7,980,000 +12% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $71,286,000 +$7,189,000 +11% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 $69,273,000 +$5,086,000 +7.9% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $68,637,000 +$4,641,000 +7.3% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 $68,110,000 +$5,334,000 +8.5% 31 Dec 2016 10-K 23 Feb 2018 2017 FY
Q3 2016 $64,097,000 +$1,237,000 +2% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $64,187,000 +$1,415,000 +2.3% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 $63,996,000 +$300,000 +0.47% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 $62,776,000 -$4,785,000 -7.1% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $62,860,000 +$10,806,000 +21% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $62,772,000 +$9,829,000 +19% 30 Jun 2015 10-Q 28 Jul 2015 2015 Q2
Q1 2015 $63,696,000 +$10,778,000 +20% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $67,561,000 +$15,283,000 +29% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $52,054,000 -$3,787,000 -6.8% 30 Sep 2014 10-Q 29 Oct 2014 2014 Q3
Q2 2014 $52,943,000 -$2,363,000 -4.3% 30 Jun 2014 10-Q 30 Jul 2014 2014 Q2
Q1 2014 $52,918,000 -$10,704,000 -17% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 $52,278,000 -$11,176,000 -18% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $55,841,000 -$10,471,000 -16% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $55,306,000 -$4,859,000 -8.1% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 $63,622,000 +$2,806,000 +4.6% 31 Mar 2013 10-Q 03 May 2013 2013 Q1
Q4 2012 $63,454,000 +$2,796,000 +4.6% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q3 2012 $66,312,000 +$17,164,000 +35% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 $60,165,000 +$11,104,000 +23% 30 Jun 2012 10-Q 27 Jul 2012 2012 Q2
Q1 2012 $60,816,000 +$12,347,000 +25% 31 Mar 2012 10-Q 27 Apr 2012 2012 Q1
Q4 2011 $60,658,000 +$11,821,000 +24% 31 Dec 2011 10-K 22 Feb 2013 2012 FY
Q3 2011 $49,148,000 +$3,376,000 +7.4% 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 $49,061,000 -$3,323,000 -6.3% 30 Jun 2011 10-Q 29 Jul 2011 2011 Q2
Q1 2011 $48,469,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 $48,837,000 31 Dec 2010 10-K 24 Feb 2012 2011 FY
Q3 2010 $45,772,000 30 Sep 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 $52,384,000 30 Jun 2010 10-Q 30 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.